Crossmark

Obesity paradox in young with myocardial infarction in China – or is this really a lean paradox?

Published Online: 2026-05-02

Authors

Lavie, Carl J. https://orcid.org/0000-0003-3906-1911
Catalfamo, Vince

Carbone, Salvatore
License Information

Text and Data Mining valid from 2026-05-02

Version of Record valid from 2026-05-02
More Information

Article History

Received: 10 March 2026

Revised: 1 April 2026

Accepted: 22 April 2026

First Online: 2 May 2026

Competing interests

: CJL is on the DSMB for Novo Nordisk for the REDEFINE 3 Trial with Cagri Sema. VC and SC do not have any conflicts.

Free to read: This content has been made available to all.

Document is current